Cerity Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99M | Buy |
114,745
+60,301
| +111% | +$1.04M | ﹤0.01% | 1219 |
|
|
2025
Q1 | $1.19M | Buy |
54,444
+7,777
| +17% | +$170K | ﹤0.01% | 1348 |
|
|
2024
Q4 | $1.48M | Buy |
46,667
+15,286
| +49% | +$484K | ﹤0.01% | 1245 |
|
|
2024
Q3 | $905K | Buy |
31,381
+23,749
| +311% | +$685K | ﹤0.01% | 1447 |
|
|
2024
Q2 | $293K | Buy |
7,632
+3,351
| +78% | +$129K | ﹤0.01% | 1833 |
|
|
2024
Q1 | $252K | Buy |
+4,281
| New | +$252K | ﹤0.01% | 1969 |
|